Key result
Gu Fangzhou’s oral polio vaccine and national surveillance drove China's polio-free certification in 2000.
Why the study?
Documenting Professor Gu Fangzhou's contributions to polio elimination in China highlights the strategies and innovations that led to national polio-free certification.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“under those circumstances, choosing the death vaccine was preferable in the aspect of personal gain and loss.”
Memorial review details how oral polio vaccine delivery and national surveillance achieved polio elimination in China, highlighting a replicable model for global eradication.
Commemorating the centenary of Professor Gu Fangzhou's birth, this memorial article documents his landmark contributions to eliminating poliomyelitis in China. It details his strategic prioritization of the live attenuated oral polio vaccine (OPV) and his team's breakthroughs in overcoming logistical hurdles through the sugar-coated pill formulation and mass immunization campaigns. Furthermore, the review highlights his development of diagnostic reagents and a national surveillance network, which culminated in China's polio-free certification in 2000. Ultimately, the paper honors Professor Gu's legacy as a trailblazing scientist, demonstrating how his low-cost, high-efficiency research model provided a replicable template for global polio eradication and laid the institutional foundation for China's modern public health system.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted a review in Poliomyelitis. Live attenuated oral polio vaccine (OPV) was evaluated. Professor Gu Fangzhou pioneered the live attenuated oral polio vaccine and a national surveillance network that culminated in China's polio-free certification in 2000.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: